These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22724223)

  • 41. Long-term results from statin trials: answers but more unresolved questions.
    De Backer GG
    Eur Heart J; 2011 Oct; 32(20):2479-80. PubMed ID: 21873709
    [No Abstract]   [Full Text] [Related]  

  • 42. Stroke--an equal opportunity for the initiation of statin therapy.
    Kent DM
    N Engl J Med; 2006 Aug; 355(6):613-5. PubMed ID: 16899782
    [No Abstract]   [Full Text] [Related]  

  • 43. Statin comparisons in controlled clinical trials.
    Citkowitz E
    Am J Cardiol; 2005 Nov; 96(10):1467-8. PubMed ID: 16275204
    [No Abstract]   [Full Text] [Related]  

  • 44. Is it not timely to consider how to balance cardiorenometabolic benefits and risks of statins?
    Koh KK
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2880-1. PubMed ID: 24794122
    [No Abstract]   [Full Text] [Related]  

  • 45. Perioperative statin therapy: understanding the evidence in a Bayesian context.
    Fleisher LA; Beattie WS
    Can J Anaesth; 2012 Jun; 59(6):511-5. PubMed ID: 22467069
    [No Abstract]   [Full Text] [Related]  

  • 46. Statin treatment in patients with elevated liver enzymes: pitch to proceed.
    Berkelhammer C; Lerma EV
    J Clin Lipidol; 2012; 6(4):310-1. PubMed ID: 22836066
    [No Abstract]   [Full Text] [Related]  

  • 47. Statin therapy after stroke or transient ischemic attack.
    Mascitelli L; Pezzetta F
    N Engl J Med; 2006 Nov; 355(22):2369-70; author reply 2370-1. PubMed ID: 17139772
    [No Abstract]   [Full Text] [Related]  

  • 48. Vascular disease: aortic plaque--dual therapy for a heterogeneous disease.
    King A
    Nat Rev Cardiol; 2013 Jul; 10(7):366. PubMed ID: 23712101
    [No Abstract]   [Full Text] [Related]  

  • 49. Cholesterol drug may help treat Alzheimer's.
    Heart Advis; 2005 Jul; 8(7):2. PubMed ID: 16180263
    [No Abstract]   [Full Text] [Related]  

  • 50. Imaging of a regressive coronary soft plaque under lipid lowering therapy by multi-slice computed tomography.
    Burgstahler C; Reimann A; Beck T; Kuettner A; Heuschmid M; Kopp AF; Schroeder S
    Int J Cardiovasc Imaging; 2006 Feb; 22(1):119-21. PubMed ID: 16374526
    [No Abstract]   [Full Text] [Related]  

  • 51. Endogenous tissue plasminogen activator and risk of recurrent cardiac events after an acute coronary syndrome in the MIRACL study.
    Kinlay S; Schwartz GG; Olsson AG; Rifai N; Bao W; Libby P; Ganz P;
    Atherosclerosis; 2009 Oct; 206(2):551-5. PubMed ID: 19394618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Invited commentary.
    Creswell LL
    Ann Thorac Surg; 2012 Jul; 94(1):14. PubMed ID: 22734976
    [No Abstract]   [Full Text] [Related]  

  • 53. The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome.
    Uzun M; Yiğiner O; Kirilmaz A
    Turk Kardiyol Dern Ars; 2009 Jul; 37(5):364; author reply 365. PubMed ID: 19875919
    [No Abstract]   [Full Text] [Related]  

  • 54. Efficacy and safety of intensive statin therapy in the elderly.
    Maroo BP; Lavie CJ; Milani RV
    Am J Geriatr Cardiol; 2008; 17(2):92-100. PubMed ID: 18326948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regression of left main coronary artery atherosclerotic stenosis after 12 years of follow-up, despite bypass surgery.
    Tsiamis E; Latsios G; Stefanadis C
    Angiology; 2007; 58(3):380-1. PubMed ID: 17626996
    [No Abstract]   [Full Text] [Related]  

  • 56. [Atorvastatin in correction of metabolic syndrome: clinico-economical assessment of efficacy].
    Khokhlov AL; Zhilina AN; Buĭdina TA
    Kardiologiia; 2006; 46(11):57-62. PubMed ID: 17183751
    [No Abstract]   [Full Text] [Related]  

  • 57. Statins, regulatory T cells, and pediatric graft coronary artery disease.
    Goldstein MR; Mascitelli L; Pezzetta F
    Pediatr Transplant; 2009 Feb; 13(1):139-40. PubMed ID: 18564306
    [No Abstract]   [Full Text] [Related]  

  • 58. Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial.
    Nicholls SJ; Cavender MA; Kastelein JJ; Schwartz G; Waters DD; Rosenson RS; Bash D; Hislop C
    Cardiovasc Drugs Ther; 2012 Feb; 26(1):71-5. PubMed ID: 22109255
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reply: is it not timely to consider how to balance cardiorenometabolic benefits and risks of statins?
    Tawakol A; Emami H; Farkouh M; Fayad ZA; Fifer K; Rudd JH; Subramanian S; Van Dyke T
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2881. PubMed ID: 24794123
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of atorvastatin on carotid atherosclerotic plaques: a randomized trial for quantitative tissue characterization of carotid atherosclerotic plaques with integrated backscatter ultrasound.
    Yamada K; Yoshimura S; Kawasaki M; Enomoto Y; Asano T; Minatoguchi S; Iwama T
    Cerebrovasc Dis; 2009; 28(4):417-24. PubMed ID: 19707015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.